My WebMD Sign In, Sign Up

Ask Your Question

WebMD Answers

120 Characters remaining
120 Characters remaining
  • First, try and keep your question as short as possible.
  • Include specific words that will help us identify questions that may already have your answer.
  • If you don't find your answer, you can post your question to WebMD Experts and Contributors.

Close

Posted: | Report This Report Question |
Q.

Why did the FDA panel oppose Avastin for treating breast cancer?

Related Topics: Breast Cancer
 

Answers From Experts & Organizations (1)

8,020 Answers
274,242 Helpful Votes
325 Followers
A.

An FDA panel has recommended that the drug Avastin no longer be sold as a treatment for breast cancer.

The unanimous recommendation came after experts concluded that Avastin offers breast cancer patients no substantial benefits but at the same time carries substantial risks.

The panel's decision does not affect other uses for which Avastin is approved, including advanced non-small-cell lung cancer, metastatic colorectal cancer, metastatic renal cell carcinoma, and glioblastoma brain tumors.

But if the FDA follows the panel's recommendation, it would be a setback for the treatment of advanced metastatic breast cancer.

The FDA panel concluded that overall, Avastin does not help breast cancer patients live substantially longer or enjoy better quality of life with the disease. The drug carries significant, sometimes fatal, cardiovascular and other side effects.

This answer should not be considered medical advice...down arrowThis answer should not be considered medical advice and should not take the place of a doctor’s visit. Please see the bottom of the page for more information or visit our Terms and Conditions.up arrow

Posted:
| Report This Report Answer
Archived: March 20, 2014

Was this helpful?

YesNo

Thanks for your feedback.

2 of 2 found this helpful
Read the Original Article: FDA Panel Opposes Avastin for Breast Cancer